UniProtKB/Swiss-Prot P35637 : Variant p.Arg521His
RNA-binding protein FUS
Gene: FUS
Feedback ?
Variant information
Variant position:
521
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Arginine (R) to Histidine (H) at position 521 (R521H, p.Arg521His).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from large size and basic (R) to medium size and polar (H)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In ALS6; results in aberrant trafficking and cytoplasmic retention of the protein.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
521
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
526
The length of the canonical sequence.
Location on the sequence:
GDRGGFGPGKMDSRGEHRQD
R RERPY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GDRGGFGPGKMDSRGEHRQDR RERPY
Mouse GDRGGFGPGKMDSRGEHRQDR RERPY
Bovine GDRGGFGPGKMDSRGEHRQDR RERPY
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 526
RNA-binding protein FUS
Region
444 – 526
Disordered
Compositional bias
509 – 526
Basic and acidic residues
Modified residue
503 – 503
Asymmetric dimethylarginine; alternate
Modified residue
503 – 503
Omega-N-methylarginine; alternate
Helix
514 – 521
Literature citations
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Kwiatkowski T.J. Jr.; Bosco D.A.; Leclerc A.L.; Tamrazian E.; Vanderburg C.R.; Russ C.; Davis A.; Gilchrist J.; Kasarskis E.J.; Munsat T.; Valdmanis P.; Rouleau G.A.; Hosler B.A.; Cortelli P.; de Jong P.J.; Yoshinaga Y.; Haines J.L.; Pericak-Vance M.A.; Yan J.; Ticozzi N.; Siddique T.; McKenna-Yasek D.; Sapp P.C.; Horvitz H.R.; Landers J.E.; Brown R.H. Jr.;
Science 323:1205-1208(2009)
Cited for: VARIANTS ALS6 CYS-244; SER-514; CYS-515; LYS-518; CYS-521; GLY-521; HIS-521; GLY-522; SER-524; THR-524 AND LEU-525; VARIANT GLN-517; SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANT ALS6 GLY-521; CHARACTERIZATION OF VARIANT GLN-517;
Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.
Vance C.; Rogelj B.; Hortobagyi T.; De Vos K.J.; Nishimura A.L.; Sreedharan J.; Hu X.; Smith B.; Ruddy D.; Wright P.; Ganesalingam J.; Williams K.L.; Tripathi V.; Al-Saraj S.; Al-Chalabi A.; Leigh P.N.; Blair I.P.; Nicholson G.; de Belleroche J.; Gallo J.M.; Miller C.C.; Shaw C.E.;
Science 323:1208-1211(2009)
Cited for: VARIANTS ALS6 GLY-514; CYS-521 AND HIS-521; SUBCELLULAR LOCATION; CHARACTERIZATION OF VARIANTS ALS6 CYS-521 AND HIS-521;
Genetic contribution of FUS to frontotemporal lobar degeneration.
Van Langenhove T.; van der Zee J.; Sleegers K.; Engelborghs S.; Vandenberghe R.; Gijselinck I.; Van den Broeck M.; Mattheijssens M.; Peeters K.; De Deyn P.P.; Cruts M.; Van Broeckhoven C.;
Neurology 74:366-371(2010)
Cited for: VARIANT ALS6 HIS-521; VARIANT VAL-254;
Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic lateral sclerosis in central-southern China.
Hou L.; Jiao B.; Xiao T.; Zhou L.; Zhou Z.; Du J.; Yan X.; Wang J.; Tang B.; Shen L.;
Sci. Rep. 6:32478-32478(2016)
Cited for: VARIANTS ALS6 HIS-521 AND TYR-526 EXT;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.